Target intelligence / Profile preview

Intestinal epithelial surface and mucus layer

Molecular classification
Other
01

Overview

The intestinal epithelial surface and mucus layer constitute a complex physiological barrier that serves as the primary interface between the host and the external environment of the gut lumen. This system consists of a specialized cellular monolayer—comprising enterocytes, goblet cells, and Paneth cells—covered by a protective, hydrated gel layer primarily composed of the MUC2 mucin glycoprotein (Johansson & Hansson, 2016). Its fundamental biological function is to facilitate the selective absorption of nutrients and water while simultaneously preventing the translocation of commensal bacteria, pathogens, and dietary antigens into the systemic circulation (Turner, 2009). In pathological states such as Ulcerative Colitis and Crohn's Disease, the integrity of this barrier is often compromised, characterized by a thinned mucus layer and increased epithelial permeability, which facilitates chronic immune activation (Okumura & Takeda, 2017). Therapeutic interventions targeting this system, such as aminosalicylates or mucosal protectants like rebamipide, aim to restore barrier function by reducing inflammation or stimulating the secretion of protective factors (McGuckin et al., 2011). Maintaining the stability of this interface is crucial for gut homeostasis and the prevention of systemic inflammatory responses.

Other names
Intestinal mucosal barrierGut barrierMucus-epithelial interfaceIntestinal mucus layer
02

Mechanism of action

Enhancement of mucosal integrity, stimulation of mucin secretion, and reduction of epithelial permeability.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Alteration of gut microbiota compositionPotential for systemic absorption of luminal toxins if barrier is compromisedRisk of masking underlying inflammatory processes
06

Interacting drugs

Mesalamine

4 more in the full profile.

07

Biomarkers

MUC2 expressionZonulinFecal calprotectinTrefoil factor 3 (TFF3)

Beyond the preview

Go deeper on Intestinal epithelial surface and mucus layer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial surface and mucus layer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call